Conceptio
›
Archive
›
ClinicalTrials.gov
ClinicalTrials.gov
public full text
N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19)
Quantinosis.ai LLC
· 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
coronavirus
covid19
coronavirus, covid19, n-acetyl glucosamine, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Sacituzumab Govitecan Plus EV in Metastatic UC
#995652
A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People Who Are Overweight or Obese
#995658
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
#995650
Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma
#995651
Effects of Multimodal Exercises Integrated With Cognitive-behavioral Therapy in Subjects With Chronic Neck Pain
#995653
Record
· ID 804454
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.